FDA Patches Error in Teva Generic Drug Yank
Published Date: 8/4/2025
Notice
Summary
The FDA fixed a previous announcement about Teva Pharmaceuticals pulling approval for 23 generic drug applications. This means some medicines made by Teva and others won’t be officially approved anymore, affecting patients and pharmacies. The correction clears up important details about when these changes happen and what it means for everyone involved.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
23 Generic Drug Approvals Withdrawn
The FDA corrected a notice that says approval was withdrawn for 23 abbreviated new drug applications. This means some medicines made by Teva Pharmaceuticals and others will no longer be officially approved, which can affect patients who take those drugs and pharmacies that dispense them. The correction clarifies timing and what the withdrawal means for everyone involved (notice originally published January 15, 2025).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in